Risk-adapted screening for prostate cancer in young men – First results of the PROBASE trial by P. Albers

Get full text

Robotic-assisted retroperitoneal lymph node dissection (RA-RPLND) for testicular cancer by A. Hiester, A. Nini, P. Albers

Get full text

Air Quality and Human Health among a Low Income Community in the Highveld Priority Area by C.Y Wright, R Oosthuizen, J John, R.M Garland, P Albers, P Albers, C Pauw

Get full text

Prevalence of tobacco use in selected Johannesburg suburbs by N Naicker, J Teare, P Albers, A Mathee

Get full text

Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in patients with testis cancer in the salvage setting by A. Nini, A. Fingerhut, G. Niegisch, A. Hiester, C. Winter, P. Albers

Get full text

Risk stratification based on size of equivocal PI-RADS lesions may safely reduce the number of MRI-targeted biopsies by D.F. Osses, C. Arsov, L. Schimmöller, P. Albers, M.J. Roobol

Get full text

Adjunctive surgery in postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) - is there always an oncologic benefit? by T. Nestler, P. Paffenholz, D. Pfister, A. Hiester, A. Nini, P. Albers, A. Heidenreich

Get full text

Preoperative clinical and radiographic predictors of major vascular reconstructions in patients with testicular cancer undergoing postchemotherapy residual tumor resection (PC-RPLN... by A. Nini, M. Boschheidgen, A. Hiester, C. Winter, G. Antoch, L. Schimmöller, P. Albers

Get full text

Do patients with advanced germ cell tumors still need Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) if the two best models predict a “benign” pathohistology?... by T. Nestler, P. Paffenholz, B. Baeßler, M. Hellmich, A. Hiester, A. Nini, D. Pfister, P. Albers, A. Heidenreich

Get full text

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate by M. Boschheidgen, L. Schimmöller, S. Doerfler, R. Al-Monajjed, J. Morawitz, F. Ziayee, D. Mally, M. Quentin, C. Arsov, P. Albers, G. Antoch, T. Ullrich

Get full text

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy by M Klingebiel, C Arsov, T Ullrich, M Quentin, R Al-Monajjed, D Mally, LM Sawicki, A Hiester, I Esposito, P Albers, G Antoch, L Schimmöller

Get full text

Effect of sexual behavior on prostate-specific antigen levels in middle-aged men screened for prostate cancer: Results from the PROBASE trial by V.H. Meissner, M. Hollerer, M. Kron, S. Schiele, P. Albers, C. Arsov, M. Kuczyk, F. Imkamp, M. Hohenfellner, V. Schütz, J.E. Gschwend, K. Herkommer

Get full text

Cost-Effectiveness of Including a Nurse Specialist in the Treatment of Urinary Incontinence in Primary Care in the Netherlands. by K M Holtzer-Goor, J G Gaultney, P van Houten, A S Wagg, S A Huygens, M M J Nielen, C P Albers-Heitner, W K Redekop, M P Rutten-van Mölken, M J Al

Get full text

Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. The importance of patient st... by C.A. Bravi, N. Fossati, G. Motterle, R.J. Karnes, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text

Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. The importance of an extensive, multi-modal ap... by C.A. Bravi, N. Fossati, G. Motterle, R.J. Karnes, D. Pfister, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text

What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? Results from a large, multi-institution... by C.A. Bravi, N. Fossati, R.J. Karnes, G. Motterle, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K-P. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text

Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. the importance of patient st... by A. Martini, N. Fossati, G. Gandaglia, C.A. Bravi, G. Motterle, R.J. Karnes, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text

What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? results from a large, multi-institution... by C.A. Bravi, N. Fossati, G. Gandaglia, A. Martini, R.J. Karnes, G. Motterle, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text

Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. the importance of an extensive, multi-modal ap... by C.A. Bravi, N. Fossati, G. Gandaglia, G. Motterle, R.J. Karnes, D. Pfister, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, A. Martini, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti

Get full text